The world's first oral GLP-1RA Novoxin (semaglutide tablets) is fully launched in China

2025-01-11 18:48:09

Novo Nordisk announced that the world's first oral glucagon-like peptide-1 receptor agonist (GLP-1RA) - Novoxin (semaglutide tablets) has been fully launched in China. With its convenient oral administration method, Novoxin helps patients benefit from GLP-1RA drugs earlier, helps achieve high-quality blood sugar targets and comprehensive metabolic management, and brings an innovative category to the clinical treatment of type 2 diabetes in China.

Novo Nordisk

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    U.S. President Trump raised the idea of a joint venture with TikTok, saying it was one of many suggestions.
                            2025-01-21

                                    Bitcoin stood above $104,000 per coin, up 4.09% on the day.
                            2025-01-17

                                    Morgan Stanley lowered its target price for Tencent Holdings from HK$570.00 to HK$550.00
                            2025-01-15

                                    US President Trump: Under a possible deal, the United States may impose some or greater degree of regulation on TikTok.
                            2025-01-21

                                    Hong Kong stocks opened: Hang Seng Index opened 1.02% higher, Hang Seng Technology Index opened 1.21% higher
                            2025-01-21